ArticleFrontiers in immunology2025
Explainable AI-enabled hybrid deep learning architecture for breast cancer detection.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Responsible artificial intelligence in medical imaging: a systematic review.Frontiers in digital health · 2026Pooled it
- Patient and Public Perceptions of Artificial Intelligence in Breast Imaging and Clinical Decision-Making: An Exploratory Cross-Sectional Survey Study.Diagnostics (Basel, Switzerland) · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Breast cancer stands is a leading prevalent and potential fatal infection affecting women worldwide, posing the requirement of a reliable and interpretable diagnostic system. The Deep Learning (DL) methods highly contribute towards medical imagery analysis but due to the black-box nature, its clinical adoption is limited due to lack of interpretability. Methods: This proposed work introduces a hybrid Deep Learning (DL) framework for that integrates three distinct convolutional neural network (CNN) pre-trained architectures: DENSENET121, Xception and VGG16. The proposed fusion strategy enhances feature representation and classification performance through model integration. To address the DL's black-box nature and promote clinical acceptance, the proposed framework incorporates an explainable artificial intelligence (XAI) component utilizing GradCAM++. Results: Experimental evaluation on benchmark breast cancer datasets demonstrates improved classification accuracy by approximately 13\% compared to individual models, demonstrating high performance of the fusion method with an accuracy of 97\%. Discussion: The use of fused DL model enhances the performance of the classification system offering higher accuracy and robust feature extraction. With the introduction of XAI, the cancer classification system presents interpretable results making it applicable in clinical contexts. GRADCAM++ method highlights the multiple lesions with finer edges from the ultrasound images that leads towards the model's predictions, offering transparency and aiding medical professionals in diagnostic validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.